Fuller Rw
Impact in
- Behavioral Neuroscience top 5%
- Stress Responses and Cortisol
- Biological Psychiatry top 10%
- Tryptophan and brain disorders
Papers in
-
- Neurotransmitter Receptor Influence on Behavior 16
- Neuroscience and Neuropharmacology Research 8
-
- Receptor Mechanisms and Signaling 4
- Co-authors
- Saunders Kb (1 shared paper)
- Journals
- Toxicology and Applied Pharmacology (1 paper)PubMed (48 papers)
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
Fuller Rw
49 papers receiving 519 citations
Peers
Comparison fields: 5 of 83
- Behavioral Neuroscience 110
- Biological Psychiatry 47
- Cellular and Molecular Neuroscience 253
- Pharmacology 108
- Endocrine and Autonomic Systems 39
Countries citing papers authored by Fuller Rw
This map shows the geographic impact of Fuller Rw's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fuller Rw with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fuller Rw more than expected).
Fields of papers citing papers by Fuller Rw
This network shows the impact of papers produced by Fuller Rw. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fuller Rw. The network helps show where Fuller Rw may publish in the future.
Co-authors
The 1 scholars most cited alongside Fuller Rw, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The involvement of serotonin in regulation of pituitary-adrenocortical function. | 1992 | 152 |
| 2 | A placebo-controlled trial of paroxetine in the treatment of major depression. | 1992 | 67 |
| 3 | Potentiation of the L-5-hydroxytryptophan-induced elevation of plasma corticosterone levels in rats by a specific inhibitor of serotonin uptake. | 1975 | 28 |
| 4 | Selective inhibition of monoamine oxidase. | 1972 | 21 |
| 5 | Influence of route of administration on potency of the selective 5HT-1A agonist, 8-hydroxy-2-(di-n-propylamino)tetralin, in rats. | 1987 | 21 |
| 6 | The human pharmacology of capsaicin. | 1990 | 21 |
| 7 | Effects of amfonelic acid, alpha-methyltyrosine, Ro 4-1284 and haloperidol pretreatment on the depletion of striatal dopamine by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice. | 1985 | 18 |
| 8 | Inhibition of drug metabolism by fluoxetine. | 1976 | 15 |
| 9 | Elevation of epinephrine concentration in rat brain by LY51641, a selective inhibitor of type A monoamine oxidase. | 1981 | 15 |
| 10 | Pharmacologic modification of serotonergic function: drugs for the study and treatment of psychiatric and other disorders. | 1986 | 13 |
| 11 | Influence of substrate in the inhibition of rat liver and brain monoamine oxidase. | 1968 | 13 |
| 12 | Biochemical pharmacology of the serotonin system. | 1986 | 13 |
| 13 | Further evidence for serotonin involvement in thermoregulation following morphine administration from studies with an inhibitor of serotonin uptake. | 1974 | 10 |
| 14 | Persistent effects of amphetamine, p-chloroamphetamine, and related compounds on central dopamine and serotonin neurons in rodents. | 1985 | 10 |
| 15 | Effect of fluoxetine pretreatment on plasma and tissue concentrations of desipramine in rats. | 1989 | 10 |
| 16 | 1975 | 10 | |
| 17 | Persistent depletion of striatal dopamine in mice by m-hydroxy-MPTP. | 1986 | 9 |
| 18 | Functional consequences of inhibiting serotonin uptake with fluoxetine in rats. | 1982 | 8 |
| 19 | Central serotonin antagonist activity of ketanserin. | 1984 | 8 |
| 20 | 6-Chloro-2-aminotetralin, a rigid Conformational analog of 4-chloroamphetamine: pharmacologic properties of it and related compounds in rats. | 1974 | 8 |
About Fuller Rw
Fuller Rw is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology, Biochemistry, Organic Chemistry and Physiology, having authored 49 papers that have together received 556 indexed citations. Recurring topics across this work include Neurotransmitter Receptor Influence on Behavior (16 papers), Neuroscience and Neuropharmacology Research (8 papers), Amino Acid Enzymes and Metabolism (6 papers), Diet and metabolism studies (5 papers), Receptor Mechanisms and Signaling (4 papers), Eicosanoids and Hypertension Pharmacology (4 papers), Cyclopropane Reaction Mechanisms (3 papers) and Pharmacology and Obesity Treatment (3 papers). The work is most often cited by research in Behavioral Neuroscience (110 citations), Biological Psychiatry (47 citations), Cellular and Molecular Neuroscience (253 citations), Pharmacology (108 citations) and Endocrine and Autonomic Systems (39 citations). Fuller Rw has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Saunders Kb. Their work appears in journals such as Toxicology and Applied Pharmacology and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.